Non-reproductive tissues and cells

Similar documents
Non-reproductive tissues and cells

Non-reproductive tissues and cells

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells

Non-reproductive tissues and cells

Non-reproductive tissues and cells Recommending authority/ association

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL

Implementation Report on the patient safety Recommendation 2009/C 151/01. Healthcare Systems Unit DG SANCO

EUROPEAN COMMISSION DIRECTORATE GENERAL FOR HEALTH AND FOOD SAFETY

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections.

Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective

Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK

Microbiology EQA Product Portfolio

Keeping the Blood Supply Safe Current and Future Strategies. Marissa Li, MD

Screening programmes for Hepatitis B/C in Europe

Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey

Pathogen Reduction/Inactivation KABB Annual Meeting Elpidio Pena, MD, MA Norton Healthcare Transfusion Services

Controls & Calibrators. Disease Quality Controls

Structure and duties of Blood service

The Technical Aspects of Pathogen Testing in Canada. Nancy Angus Canadian Blood Services Director, Testing

Item 2.2 Household definition

Directed Semen Donor Eligibility Requirements

New trends in harm reduction in Europe: progress made challenges ahead

Increase in Locally-Acquired Cyclosporiasis Cases in Ontario

Laboratory diagnostics of blood-borne infections related to blood transfusions and transplantations

Optimal / Evidence-based Method to Prevent Transmission of Cytomegalovirus (CMV) by Transfusion

Keeping blood transfusions safe:

Surveillance Report 2014

List of nationally authorised medicinal products

DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations

VARIATIONS : IMPACT ON ADMINISTRATIVE BURDEN AND FEES. Rose-Marie Molina EMA Infoday London, 14th March 2014

Increased Risk Donors. November 1, 2018 BC Kidney Days. Jagbir Gill MD MPH Associate Professor of Medicine UBC

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

AMPLIRUN TOTAL A RELIABLE QUALITY CONTROL SOURCE FOR NUCLEIC ACID TESTS

Immunohistochemical Confirmation of Infections

Patient reporting update

For more information about how to cite these materials visit

Organ Transplant Systems in the EU : A selected overview

Emerging Pathogens that Impact the Canadian Blood Supply Alberta Vein to Vein Conference March 18-19, 2016

Storage conditions. roomtemperature or incubator at 36 C. Other: 2-8 C Blood: roomtemperature or incubator at. A.s.a.p. max 24h. A.s.a.p.

HEALTH SCREENING QUESTIONNAIRE. Work-up. Donor ID EdgeCell #:

Results of the Survey addressed to the EU Member States about quantification of food waste and preventing Food waste Brussels,

Consequence of the change in the definition of. an agricultural parcel

Pharmaceutical Pricing & Reimbursement Information. PPRI Project Co-ordination Sabine Vogler, Gesundheit Österreich GmbH

LIMITE EN COUNCIL OF THE EUROPEAN UNION. Brussels, 7 July /11 LIMITE ENFOPOL 228 DAPIX 81

Surveillance Report 2015

Egg and Sperm Bank Edinburgh Fertility & Reproductive Endocrine Centre (EFREC) DONOR INFORMATION Screening Tests

TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE MEETING October2010. Issue Summary

Blood Screening Assays. CTS lab locations where assays are performed are indicated by alpha codes D, P, and T.

Programme Groupings. For 2013, the preliminary molecular external quality assessment (EQA) programme schedule has been displayed by Disease Group.

Answering your daily challenges. in the ELISA technology I N FECTI OUS DISEASES. bioelisa

Laboratory Survey Results. Preventing disease, promoting and protecting health

Trends in injecting drug use in Europe

HPSC - Weekly Infectious Disease Report

DS-EIA-ANTI-HIV-UNIF (Ab) I DS-EIA-ANTI-HIV-UNIF (Ab) I DS-EIA-ANTI-HIV-UNIF (Ab) I

Agencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State)

Guidance on Performance Evaluation of In-vitro Diagnostic Medical Devices

+ Intermittent shedding in urine, + Urinary tract

Attention. Therefore, all the data and statements made in this presentation are preliminary and might change in the future.

Surveillance Report 2016

Table of Contents (continued)

Transfusion transmitted infections in National Haemovigilance Systems: the Greek experience

A Transfusion Reaction What Do I Do Now? Judith A. Sullivan, MS, MT(ASCP)SBB, CQA(ASQ) ASCLS Region III Triennial Meeting Birmingham AL

'SECTION B EU PARTY. The following abbreviations are used:

Transmission, processing and publication of HBS 2015 data

EUROPEAN MEDICINES AGENCY DECISION. of 20 July 2008

Seasonal influenza vaccination Recommendations & Reality

ANNUAL REPORT on surveillance for avian influenza in poultry in the EU in 2009

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

HPSC - Weekly Infectious Disease Report

The testing of Donated Blood and Components at NHSBT

"Wanted Poster" Diseases

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report

Brussels, XXX SANCO/10181/2014 [ ](2014) XXX draft

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Confirmatory Testing Algorithm. Routine Donor Testing Algorithm

EU School Fruit, Vegetables & Milk Scheme 2017/2023

2017 CST-Astellas Canadian Transplant Fellows Symposium. Optimizing use of organs from Increased Risk Donors

Size nm m m

Tel: Tel: Web: CODE DESCRIPTION UNITS

ANSES. Agence Nationale du Médicament Vétérinaire (National Agency for Veterinary Drugs) (Reference Member State) BP FOUGERES CEDEX FRANCE

Competent Authorities on Substances of Human Origin Expert Group (CASoHO E01718) Meeting of the Competent Authorities on Blood and Blood Components

CONTACTS & ACKNOWLEDGEMENTS

Laboratory Evidence of Human Viral and Selected Non-viral Infections in Canada

MOLECULAR DIAGNOSTIC PANELS and REAGENT KITS for NUCLEIC ACID EXTRACTION and RT-PCR of INFECTIOUS DISEASES and GENOMICS. Sep 2018

About HPV. Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. Theree are more than 100 types of HPV, of which at

MP Biomedicals Asia Pacific Pte. Ltd. (formerly Genelabs Diagnostics Pte. Ltd.)

EDUCATIONAL COMMENTARY EMERGING INFECTIOUS DISEASE AGENTS

Transcription:

Colour key Minimum requirements as set out in Directive 2004/23/EC and its technical Directives (particularly 2006/17/EC) More stringent -legally binding, applies for all donations and all donor profiles More stringent - legally binding, performed under specific conditions (for details consult the sheets for each member state) More stringent - recommended on national level, applies for all types of donations and all donor profiles More stringent - recommended on national level, performed under specific conditions (for details consult the sheets for each member state) Testing is not legally binding and not recommended on national level Please consult the member state fact sheet for further information VIRAL HIV 1 and HIV 2 Hepatitis B Hepatitis C HTLV-1 Non-reproductive tissues and cells Anti-HIV 1 Anti-HIV 2 HIV 1p24 HIV NAT HBs Ag Anti-HBc Anti - HBs HBV NAT Anti-HCV HCV NAT HTA HTLV-2 Chikungunya virus Cytomegalovirus Dengue Virus Ebola Virus Anti-HTLV-1 HTLV-1 NAT Anti-HTLV-2 HTLV-2 NAT Anti-CHIKV CHIKV NAT Anti-CMV CMV NAT Anti-DENV Dengue NAT Ebola NAT

Epstein-Barr virus Anti-EBV Hepatitis E Anti-HEV HEV NAT Human Parvovirus B19 HPVB19 NAT Herpes simplex virus HSV Ag HSV Ab HSV NAT West Nile Virus WNV minipool NAT WNV ID NAT specify pathogen specify technique PARASITIC Babesiosis Leishmaniasis Malaria Toxoplasmosis Microscopy Antibody detection (EIA, IFA) Molecular (NAT) Microscopy Anti-Leishmania sp. Leishmania sp. NAT Microscopy Plasmodium sp. Ab Plasmodium sp. Ag Plasmodium sp. Ag - rapid test Plasmodium sp. NAT HTA

Trypanosomiasis specify pathogen BACTERIAL Treponema pallidum (Syphilis) Chlamydia trachomatis Neisseria gonorrhoeae Brucellosis Tuberculosis Q-fever specify pathogen Anti-Toxoplasma gondii Microscopy Anti-Trypanosoma cruzi Microscopy specify technique Anti-T. pallidum Microscopy T. pallidum NAT C. trachomatis DFA C. trachomatis EIA C. trachomatis NAT N. gonorrhoeae NAT C. burnetii Ab C. burnetii NAT Microscopy specify technique FUNGI specify pathogen specify technique Transmissible spongiform encephalopathies Other Tests ABO blood group Prion (PrP) detection ABO typing HTA

RhD blood group HLA Genetic, please specify condition RhD typing HLA Ab HLA Ag HLA gene Specify technique HTA

Colour key Minimum requirements as set out in Directive 2004/23/EC and its technical Directives (particularly 2006/17/EC) More stringent -legally binding, applies for all donations and all donor profiles More stringent - legally binding, performed under specific conditions (for details consult the sheets for each member state) More stringent - recommended on national level, applies for all types of donations and all donor profiles More stringent - recommended on national level, performed under specific conditions (for details consult the sheets for each member state) Testing is not legally binding and not recommended on national level Please consult the Member State fact sheet for further information Mapping of More Stringent Donor Testing Requirements for Non-Reproductive Tissues and Cells - 2015 Tested pathogen Donor test/ technique AT BE BG CY CZ DE DK EE EL ES FI FR HR HU IE IT LT LU LV MT NL NO PL PT RO SE SI SK UK VIRAL HIV 1 and HIV 2 Hepatitis B Hepatitis C HTLV-1 HTLV-2 Chikungunya virus Cytomegalovirus Dengue Virus Ebola Virus Epstein-Barr virus Hepatitis E Human Parvovirus B19 Reproductive tissues and cells Anti-HIV 1 Anti-HIV 2 HIV 1p24 HIV NAT HBs Ag Anti-HBc Anti-HBs HBV NAT Anti-HCV HCV NAT Anti-HTLV-1 HTLV-1 NAT Anti-HTLV-2 HTLV-2 NAT Anti-CHIKV CHIKV NAT Anti-CMV CMV NAT Anti-DENV NAT NAT Anti-EBV Anti-HEV HEV NAT HPVB19 NAT HFEA

Tested pathogen Donor test/ technique AT BE BG CY CZ DE DK EE EL ES FI FR HR HU IE IT LT LU LV MT NL NO PL PT RO SE SI SK UK Herpes simplex virus HSV Ag HSV Ab HSV NAT West Nile Virus WNV minipool NAT WNV ID NAT specify pathogen specify technique PARASITIC Babesiosis Microscopy Antibody detection (EIA, IFA) Molecular (NAT) HFEA Leishmaniasis Microscopy Anti-Leishmania sp. Leishmania sp. NAT Malaria Microscopy Plasmodium sp. Ab Plasmodium sp. Ag Plasmodium sp. Ag - rapid test Plasmodium sp. NAT Toxoplasmosis Anti-Toxoplasma gondii Microscopy Trypanosomiasis Anti-Trypanosoma cruzi Microscopy specify pathogen specify technique BACTERIAL Treponema pallidum (Syphilis) Chlamydia trachomatis Neisseria gonorrhoeae Anti-T. pallidum Microscopy T. pallidum NAT C. trachomatis DFA C. trachomatis EIA C. trachomatis NAT N. gonorrhoeae NAT

Tested pathogen Donor test/ technique AT BE BG CY CZ DE DK EE EL ES FI FR HR HU IE IT LT LU LV MT NL NO PL PT RO SE SI SK UK Brucellosis Tuberculosis Q-fever C. burnetii Ab C. burnetii NAT Microscopy specify pathogen specify technique FUNGI specify pathogen Transmissible spongiform Other Tests ABO blood group RhD blood group HLA Genetic, please specify condition specify technique Prion (PrP) detection ABO typing RhD typing HLA Ab HLA Ag HLA gene Specify technique HFEA